Athersys Inc - Company Profile
Powered by 
All the sales intelligence you need on Athersys Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Athersys Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Athersys Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Athersys Inc (Athersys) is a biotechnology company that discovers and develops novel and proprietary therapies in the field of regenerative medicine. It is investigating its lead platform, MultiStem, a patented stem cell therapy for treating chronic conditions such as cardiovascular diseases, inflammatory and immune disorders, neurological, and pulmonary disorders. The company’s MultiStem program includes product candidates at various levels of clinical trials for treating acute myocardial infarction, traumatic brain injury, vascular disease, acute pulmonary distress, wound healing, organ reperfusion, bone marrow transplant support, ischemic stroke, and autoimmune disease. Athersys is headquartered in Cleveland, Ohio, the US.
Headquarters
United States of America
Address
3201 Carnegie Avenue, Cleveland, Ohio, 44115
Telephone
1 216 4319900
No of Employees
24
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
ATHXQ (OTC)
Revenue (2022)
$5.3M
-3.4%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
16.6%
(2022 vs 2021)
Net Profit Margin (2022)
XYZ
13.6%
(2022 vs 2021)
* As of and is in US$
Athersys Inc premium industry data and analytics
Products and Services
| Products |
|---|
| Pipeline |
| MultiStem |
| Ischemic Stroke- Phase III |
| XYZ |
| XYZ |
| XYZ |
Competitor Comparison
| Key Parameters | Athersys Inc | Johnson & Johnson | Pfizer Inc | Vericel Corp | Cryo-Cell International Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Cleveland | New Brunswick | New York City | Cambridge | Oldsmar |
| State/Province | Ohio | New Jersey | New York | Massachusetts | Florida |
| No. of Employees | 24 | 138,100 | 81,000 | 357 | 82 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Jane Wasman | Chairman | Executive Board | 2023 | 66 |
| Daniel A. Camardo | Chief Executive Officer; Director | Executive Board | 2022 | 54 |
| Maia Hansen | Chief Operating Officer | Senior Management | 2022 | 54 |
| Kasey Rosado | Chief Financial Officer - Interim | Senior Management | 2022 | 49 |
| Manal Morsy, M.D., Ph.D. | Executive Vice President; Head - Global Regulatory Affairs | Senior Management | 2016 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer